FR3138980B3 - COMPOSITION COMPRENANT DE L’ALPHA-S1-CASEINE HYDROLYSEE et un hydrolysat de protéine de poisson - Google Patents

COMPOSITION COMPRENANT DE L’ALPHA-S1-CASEINE HYDROLYSEE et un hydrolysat de protéine de poisson Download PDF

Info

Publication number
FR3138980B3
FR3138980B3 FR2208642A FR2208642A FR3138980B3 FR 3138980 B3 FR3138980 B3 FR 3138980B3 FR 2208642 A FR2208642 A FR 2208642A FR 2208642 A FR2208642 A FR 2208642A FR 3138980 B3 FR3138980 B3 FR 3138980B3
Authority
FR
France
Prior art keywords
composition
casein
protein hydrolyzate
fish protein
dog
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR2208642A
Other languages
English (en)
Other versions
FR3138980A3 (fr
Inventor
Michael Donabedian
Claude Beata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vetoquinol SA
Original Assignee
Vetoquinol SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vetoquinol SA filed Critical Vetoquinol SA
Priority to FR2208642A priority Critical patent/FR3138980B3/fr
Priority to PCT/EP2023/073422 priority patent/WO2024046922A1/fr
Priority to EP23762396.2A priority patent/EP4580649A1/fr
Priority to CA3259974A priority patent/CA3259974A1/fr
Priority to US18/879,708 priority patent/US20250387448A1/en
Priority to AU2023331700A priority patent/AU2023331700A1/en
Publication of FR3138980A3 publication Critical patent/FR3138980A3/fr
Application granted granted Critical
Publication of FR3138980B3 publication Critical patent/FR3138980B3/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/20—Animal feeding-stuffs from material of animal origin
    • A23K10/22—Animal feeding-stuffs from material of animal origin from fish
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/20—Animal feeding-stuffs from material of animal origin
    • A23K10/26—Animal feeding-stuffs from material of animal origin from waste material, e.g. feathers, bones or skin
    • A23K10/28—Animal feeding-stuffs from material of animal origin from waste material, e.g. feathers, bones or skin from waste dairy products
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/105—Aliphatic or alicyclic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Husbandry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Neurosurgery (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Birds (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Fodder In General (AREA)

Abstract

La présente invention se rapporte à une nouvelle composition comprenant de l’alpha-s1-caséine hydrolysée et un hydrolysat de protéine de poisson, son procédé de fabrication et l’utilisation de la composition dans un complément alimentaire, sous forme solide ou liquide, pour animaux domestiques, en particulier pour les chats et les chiens. Les compositions selon l’invention sont en outre destinées à être administrées par voie orale pour aider l’animal de préférence domestique, en particulier le chien ou le chat, à surmonter les situations générant des troubles anxieux, notamment les troubles liés à la séparation, et à retrouver un comportement équilibré. La présente invention trouve par exemple des applications dans le domaine vétérinaire, plus particulièrement dans le domaine des compléments alimentaires vétérinaires ou des snacks, friandises ou bouchées pour animaux de compagnie, en particulier pour le chien ou le chat. Il n’y a pas de figure.
FR2208642A 2022-08-29 2022-08-29 COMPOSITION COMPRENANT DE L’ALPHA-S1-CASEINE HYDROLYSEE et un hydrolysat de protéine de poisson Active FR3138980B3 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR2208642A FR3138980B3 (fr) 2022-08-29 2022-08-29 COMPOSITION COMPRENANT DE L’ALPHA-S1-CASEINE HYDROLYSEE et un hydrolysat de protéine de poisson
PCT/EP2023/073422 WO2024046922A1 (fr) 2022-08-29 2023-08-25 Composition comprenant de l'alpha-s1-caseine hydrolysee et un hydrolysat de proteine de poisson
EP23762396.2A EP4580649A1 (fr) 2022-08-29 2023-08-25 Composition comprenant de l'alpha-s1-caseine hydrolysee et un hydrolysat de proteine de poisson
CA3259974A CA3259974A1 (fr) 2022-08-29 2023-08-25 Composition comprising hydrolysed alpha-s1-casein and fish protein hydrolysate
US18/879,708 US20250387448A1 (en) 2022-08-29 2023-08-25 Composition comprising hydrolyzed alpha-s1-casein and a fish protein hydrolysate
AU2023331700A AU2023331700A1 (en) 2022-08-29 2023-08-25 Composition comprising hydrolysed alpha-s1-casein and fish protein hydrolysate

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2208642A FR3138980B3 (fr) 2022-08-29 2022-08-29 COMPOSITION COMPRENANT DE L’ALPHA-S1-CASEINE HYDROLYSEE et un hydrolysat de protéine de poisson
FR2208642 2022-08-29

Publications (2)

Publication Number Publication Date
FR3138980A3 FR3138980A3 (fr) 2024-03-01
FR3138980B3 true FR3138980B3 (fr) 2024-09-13

Family

ID=87886731

Family Applications (1)

Application Number Title Priority Date Filing Date
FR2208642A Active FR3138980B3 (fr) 2022-08-29 2022-08-29 COMPOSITION COMPRENANT DE L’ALPHA-S1-CASEINE HYDROLYSEE et un hydrolysat de protéine de poisson

Country Status (6)

Country Link
US (1) US20250387448A1 (fr)
EP (1) EP4580649A1 (fr)
AU (1) AU2023331700A1 (fr)
CA (1) CA3259974A1 (fr)
FR (1) FR3138980B3 (fr)
WO (1) WO2024046922A1 (fr)

Also Published As

Publication number Publication date
AU2023331700A1 (en) 2025-01-09
US20250387448A1 (en) 2025-12-25
CA3259974A1 (fr) 2024-03-07
WO2024046922A1 (fr) 2024-03-07
FR3138980A3 (fr) 2024-03-01
EP4580649A1 (fr) 2025-07-09

Similar Documents

Publication Publication Date Title
Kumari et al. Evaluation of the antibacterial activity of skin mucus of three carp species
Lubzens et al. Biotechnology and aquaculture of rotifers
US20200221732A1 (en) Essential oil particles with improved stability and compositions thereof
MXPA03006663A (es) Genes de desaturasa y usos de los mismos.
FR3138980B3 (fr) COMPOSITION COMPRENANT DE L’ALPHA-S1-CASEINE HYDROLYSEE et un hydrolysat de protéine de poisson
Stojanovic et al. Macrophage migration inhibitory factor deficiency protects pancreatic islets from cytokine-induced apoptosis in vitro
KR20020042877A (ko) 번식용 암퇘지의 사육 방법 및 번식용 암퇘지용 사료
You et al. Comparison of the growth performance and long-chain PUFA biosynthetic ability of the genetically improved farmed tilapia (Oreochromis niloticus) reared in different salinities
Lloyd Essential fatty acids and skin disease
Xu et al. Morphology, sex steroid level and gene expression analysis in gonadal sex reversal of triploid female (XXX) rainbow trout (Oncorhynchus mykiss)
TW200305372A (en) Feed for fish and use thereof
CN106102475A (zh) 富含瘤胃不稳定成分的颗粒的反刍动物饲料
FR3071704B1 (fr) Composition appetente comprenant de l'alpha-s1-caseine hydrolysee
Paziewska-Harris et al. Quantitative analysis of Cryptosporidium growth in in vitro culture—the impact of parasite density on the success of infection
JP2006519587A (ja) 組成物及び方法
Barry et al. Effects of Anti‐phospholipase A2 on the Growth of Rainbow Trout
Alarcon et al. The effect of proteinase inhibitors in food protein hydrolysis by digestive proteinases of white shrimp (Penaeus vannamei) larvae
Mueller et al. WAVD Clinical consensus guidelines for demodicosis
JPH10327766A (ja) 尿石症治療用飼料組成物およびその製造方法
CN1046189A (zh) 羊生长激素
CA2316731A1 (fr) Composition antipyretique concentree et stabilisee a usage veterinaire destinee a etre incorporee a l'alimentation des animaux ainsi que procede d'incorporation de cette composition a l'eau de boisson d'animaux
Petrushko et al. MONITORING OF PRODUCTION LEVEL OF RECOMBINANT HUMAN PROLONGED LACTATION LACTOFERRIN IN MILK OF GENETICALLY MODIFIED GOATS DURING
Rawdon et al. Systemic granulomatous and haemorrhagic syndrome in New Zealand dairy cattle
Salohub Influence of genotypic and parathipic factors on the traits of milk production of cows Ukrainian Red-and-White dairy breed
Allender et al. Hypothyroidism in an African forest buffalo (Syncerus caffer nanus)

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4